1. In pretreated patients with nucleophosmin 1-mutated (NPM1m) acute myeloid leukemia (AML), nearly half of patients treated with revumenib showed...
1. Curry and colleagues tested an artificial intelligence (AI) software that guided non-radiology specialists in diagnosing proximal deep vein thrombosis...
1. Hemoglobin response was significantly greater in the treatment group compared to placebo. 2. Majority of adverse events were mild...
1. Recurrent ischemic stroke rates were significantly reduced in patients who started DOAC within 4 days of an acute ischemic...
1. Higher red cell distribution width to albumin ratio (RAR) values were associated nonlinearly with a higher mortality risk. 2....
1. In this prospective cohort study, a single intravenous dose of scAAV2/8-LP1-hFIXco gene therapy in men with severe hemophilia B...
1. This case series identified three non-coding erythropoietin (EPO) variants that significantly increased gene expression under hypoxic conditions. 2. The...
1. Among patients with active cancer and prior venous thromboembolism (VTE), extended treatment with reduced-dose apixaban demonstrated noninferior efficacy to...
1. The risk of bloodstream infections (BSIs) in individuals with indwelling peripheral intravenous catheters (PIVCs) is significantly increased after 3...
1. In this cohort of individuals with hemophilia, the physical activity levels and step count did not significantly differ between...
